ToolGen, Inc., Demonstrates CRISPR/cas9 Gene Editing Improves Anti-Tumor Activity of Human CAR-T Cells – GlobeNewswire (press release)
|
ToolGen, Inc., Demonstrates CRISPR/cas9 Gene Editing Improves Anti-Tumor Activity of Human CAR-T Cells
GlobeNewswire (press release) The poster, entitled “CRISPR/Cas9-Mediated Knockout of DGK Improves Anti-Tumor Activities of Human T Cells” (Abst. #114), examined the anti-tumor activity of T cells in a solid tumor model where immune cell function is highly limited. Diacylglycerol … |
